SCHEMBL17301730

SCHEMBL17301730

Cc1ccccc1Sc1ccccc1Sc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
HTR1A P08908 3/20 0.43
HTR3A P46098 3/20 0.43
HAO1 Q9UJM8 1/20 0.43
SIRT1 Q96EB6 1/20 0.42
AR P10275 2/20 0.42
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
NSD2 O96028 1/20 0.41
MAPK1 P28482 1/20 0.41
FFAR1 O14842 1/20 0.40
TDP1 Q9NUW8 2/20 0.40
IDO1 P14902 1/20 0.40
TSHR P16473 1/20 0.39
ACHE P22303 1/20 0.39
CHRNA7 P36544 2/20 0.39
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2876479 0.95 L3MBTL1 (0.50) L3MBTL1HTR1AHTR3AHAO1SIRT1
SCHEMBL29580858 0.95 L3MBTL1 (0.50) L3MBTL1HTR1AHTR3AHAO1SIRT1
SCHEMBL15906499 0.88 HTR1A (0.50) L3MBTL1HTR1AHTR3AHAO1AR
SCHEMBL3900082 0.85 SIRT1 (0.52) L3MBTL1HTR1AHTR3ASIRT1MAPT
SCHEMBL3897215 0.85 SIRT1 (0.52) L3MBTL1HTR1AHTR3ASIRT1MAPT
SCHEMBL576094 0.85 ACHE (0.53) L3MBTL1HTR1AHTR3AHAO1AR
Phosphine SCHEMBL29157942 0.83 HTR1A (0.50) L3MBTL1HTR1AHTR3AHAO1AR
Hydrogen Sulfide SCHEMBL11580912 0.83 HTR1A (0.50) L3MBTL1HTR1AHTR3AHAO1AR
SCHEMBL29031117 0.83 HTR1A (0.55) L3MBTL1HTR1AHTR3AHAO1AR
SCHEMBL15418919 0.83 AR (0.43) L3MBTL1HTR1AHTR3AHAO1SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3205640-A1 MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2017-08-16 EP disclosed
EP-3032333-B1 SHRINK MATERIAL AND PATTERN FORMING PROCESS SHINETSU CHEMICAL CO (JP) 2017-05-24 EP disclosed
EP-3168207-A1 MONOMER, POLYMER, RESIST COMPOSITION, AND PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2017-05-17 EP disclosed
US-20150346599-A1 PHOTO-DESTROYABLE QUENCHER AND ASSOCIATED PHOTORESIST COMPOSITION, AND DEVICE-FORMING METHOD ROHM AND HAAS ELECTRONIC MATERIALS LLC 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150346599-A1 PHOTO-DESTROYABLE QUENCHER AND ASSOCIATED PHOTORESIST COMPOSITION, AND DEVICE-FORMING METHOD CBR3, RB1, C1R L3MBTL1 368/4885HTR1A 2046/4885HTR3A 2491/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.